AI assistant
CODA MINERALS LTD — Director's Dealing 2023
Dec 5, 2023
64682_rns_2023-12-05_1387bf7d-0ad2-4a33-a45a-488b32b2f310.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3Y Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity Coda Minerals Ltd ABN 49 625 763 957
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | Christopher Stevens |
|---|---|
| Date of last notice | 14 August 2023 |
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Direct or indirect interest | Indirect |
|---|---|
| Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. |
Dr Catriona Fleur Stevens –spouse |
| Date of change | 6 December 2023 |
| No. of securities held prior to change | Christopher Stevens 358,174 fully paid ordinary shares Dr Catriona Fleur Stevens –spouse 226,030 fully paid ordinary shares 2,000,000 options, exercise price $0.2145 and expiring on 3 July 2024 34,416 2021 Performance Rights 314,402 2022 Performance Rights Loutre Investments Pty Ltd **SMSF A/C> -director of trustee and beneficiary of account 295,833 fully paid ordinary shares |
- See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Appendix 3Y Change of Director’s Interest Notice
| Class | Performance Rights - expiring 13 November 2023 |
|---|---|
| Number acquired | 4,246,705 |
| Number disposed | Nil |
| Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation |
Nil. Issued pursuant to shareholder approval obtained at the 2023 AGM held on 10 November 2023. |
| No. of securities held after change | Christopher Stevens 358,174 fully paid ordinary shares Dr Catriona Fleur Stevens –spouse 226,030 fully paid ordinary shares 2,000,000 options, exercise price $0.2145 and expiring on 3 July 2024 34,416 2021 Performance Rights 314,402 2022 Performance Rights 4,246,705 Performance Rights (expiring 13 November 2028) Loutre Investments Pty Ltd **SMSF A/C> -director of trustee and beneficiary of account 295,833 fully paid ordinary shares |
| Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back |
Issue of 823,727 CEO Service Rights and 3,422,978 CEO Performance Rights both expiring on 13 November 2028 following shareholder approval obtained at the 2023 AGM held on 10 November 2023. |
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Detail of contract | N/A |
|---|---|
| Nature of interest | |
| Name of registered holder (if issued securities) |
|
| Date of change |
- See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011
Appendix 3Y Change of Director’s Interest Notice
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change
Part 3 –[+] Closed period
Were the interests in the securities or contracts detailed No above traded during a[+] closed period where prior written clearance was required? If so, was prior written clearance provided to allow the trade N/A to proceed during this period? If prior written clearance was provided, on what date was this N/A provided?
- See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 3